Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Argenx Se ADR (ARGX)

Argenx Se ADR (ARGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 32,845,396
  • Shares Outstanding, K 61,060
  • Annual Sales, $ 2,252 M
  • Annual Income, $ 833,040 K
  • EBIT $ 211 M
  • EBITDA $ 228 M
  • 60-Month Beta 0.39
  • Price/Sales 14.66
  • Price/Cash Flow 182.03
  • Price/Book 5.98

Options Overview Details

View History
  • Implied Volatility 33.51% ( -0.23%)
  • Historical Volatility 40.24%
  • IV Percentile 44%
  • IV Rank 29.05%
  • IV High 51.97% on 06/21/24
  • IV Low 25.95% on 01/22/25
  • Put/Call Vol Ratio 1.09
  • Today's Volume 289
  • Volume Avg (30-Day) 228
  • Put/Call OI Ratio 0.44
  • Today's Open Interest 9,982
  • Open Int (30-Day) 8,269

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 27 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate 2.87
  • Number of Estimates 11
  • High Estimate 3.53
  • Low Estimate 2.19
  • Prior Year 0.45
  • Growth Rate Est. (year over year) +537.78%

Price Performance

See More
Period Period Low Period High Performance
1-Month
537.75 +0.03%
on 06/18/25
595.02 -9.60%
on 05/27/25
-27.71 (-4.90%)
since 05/16/25
3-Month
519.70 +3.51%
on 04/09/25
658.92 -18.36%
on 05/05/25
-73.26 (-11.99%)
since 03/18/25
52-Week
379.39 +41.79%
on 06/20/24
678.21 -20.69%
on 01/14/25
+159.96 (+42.32%)
since 06/18/24

Most Recent Stories

More News
Exelixis' Q1 Earnings: Will Cabometyx Maintain Momentum?

Investors will focus on lead drug Cabometyx’s performance when Exelixis EXEL reports first-quarter 2025 results shortly.The Zacks Consensus Estimate for sales and earnings is pegged at $502.8 million...

AZN : 70.76 (-0.30%)
VRTX : 448.40 (+1.45%)
EXEL : 40.74 (-1.48%)
ARGX : 537.92 (-0.52%)
AMGN Stock Falls Despite Upbeat Data on Immunology Drugs: Here's Why

Shares of Amgen AMGN fell by more than 5% on Wednesday after it reported top-line data on two different drugs in the autoimmune disease space. While the studies did meet their respective primary endpoints,...

REGN : 513.58 (+0.93%)
ARGX : 537.92 (-0.52%)
AMGN : 289.63 (-0.14%)
SNY : 47.62 (-1.24%)
5 Biotech Stocks That Could Be Big Winners in 2024 and Beyond

These five biotech companies could have a lot of room to run.

IMVT : 15.86 (+3.59%)
BGNE : 184.71 (+0.49%)
CRSP : 44.43 (+2.87%)
ARGX : 537.92 (-0.52%)
AMGN : 289.63 (-0.14%)
Carlyle Group, Seadrill rise; PG&E, Argenx fall, Tuesday, 11/28/2023

Stocks that traded heavily or had substantial price changes on Tuesday: Carlyle Group, Seadrill rise; PG&E, Argenx fall

TWLO : 116.68 (+0.31%)
PCG : 14.07 (+3.84%)
WPC : 63.71 (+1.13%)
ARGX : 537.92 (-0.52%)
SDRL : 28.47 (-0.32%)
These 2 Stocks Are Falling in a Fading Rally

It's been a good month, but the stock market's looking tired.

ZS : 305.41 (-0.62%)
ARGX : 537.92 (-0.52%)
Why Immunovant Stock Is Bolting Higher Today

The company may have best-in-class autoimmune disease therapy under its roof.

IMVT : 15.86 (+3.59%)
JNJ : 150.73 (-1.08%)
ARGX : 537.92 (-0.52%)
ROIV : 11.44 (+2.97%)
Argenx's 28% Surge & Promising Product Propel Investor Confidence

Argenx's chart is forming a bullish base after a 28% jump after positive clinical trials. Analysts believe the immunology specialist is an acquisition target.

ANAB : 23.39 (-1.81%)
VIE : 53.01 (unch)
ABCL : 3.47 (+11.22%)
AZN : 70.76 (-0.30%)
ALNY : 312.32 (+1.17%)
INCY : 68.27 (-0.78%)
ABBV : 185.49 (+0.01%)
ARGX : 537.92 (-0.52%)
REGN : 513.58 (+0.93%)
AMGN : 289.63 (-0.14%)
BMY : 46.84 (-0.83%)
Is Argenx Stock a Buy Now?

Good news keeps rolling in for the biotech.

ARGX : 537.92 (-0.52%)
Why Shares of Argenx Jumped This Week

The company's lead therapy showed progress in treating an autoimmune disorder.

ARGX : 537.92 (-0.52%)
Why Argenx Stock Is on Fire Today

A major clinical win is boosting the drugmaker's shares today.

ARGX : 537.92 (-0.52%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

argenx SE is a biopharmaceutical company. It focuses on developing antibody-based therapies for the treatment of autoimmune diseases and cancer. The company's product pipeline consists of ARGX-113, ARGX-110 and ARGX-111 which are in clinical trials. argenx SE is based in Breda, the Netherlands.

See More

Key Turning Points

3rd Resistance Point 552.88
2nd Resistance Point 549.82
1st Resistance Point 543.87
Last Price 537.92
1st Support Level 534.86
2nd Support Level 531.80
3rd Support Level 525.85

See More

52-Week High 678.21
Fibonacci 61.8% 564.06
Last Price 537.92
Fibonacci 50% 528.80
Fibonacci 38.2% 493.54
52-Week Low 379.39

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar